Plus Therapeutics, Inc. Recorded Big Gain

Plus Therapeutics, Inc. (PSTV:NASDAQ) soared at $1.44, representing a gain of 311.4%. On Thu, Mar 06, 2025, PSTV:NASDAQ touched a New 2-Week High of $1.44. The stock appeared on our News Catalysts scanner on Thu, Mar 06, 2025 at 11:05 AM in the 'BIOTECH' category. From Fri, Feb 21, 2025, the stock recorded 33.33% Up Days and 30.00% Green Days

About Plus Therapeutics, Inc. (PSTV:NASDAQ)

Cytori Therapeutics Inc is a specialty therapeutics company. It focuses to provide meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers. The company has two therapeutic development platforms: Cytori Cell Therapy (CCT) and Cytori Nanomedicine. The CCT platform is based on the scientific discovery that the human adipose or fat tissue compartment is a source of a mixed population of stem, progenitor and regenerative cells. The Cytori Nanomedicine Platform features a versatile and novel protein-stabilized liposomal nanoparticle technology for drug encapsulation that provides the foundation to bring two drugs into early/ late-stage clinical trials.